Pharmacotherapy, thrombolytic agent: Difference between revisions

From CCMDB Wiki
Jump to navigation Jump to search
m (Text replacement - "{{CCI category| " to "{{CCI category|")
m (Text replacement - "(.*) used appropriately, adverse effect \(reaction, allergy, hypersensitivity\)" to "$1, adverse effect")
Line 33: Line 33:


== Related ICD10 Codes ==
== Related ICD10 Codes ==
* [[Thrombolytic drug used appropriately, adverse effect (reaction, allergy, hypersensitivity)]]
* [[Thrombolytic drug, adverse effect]]


== Related Articles ==
== Related Articles ==

Revision as of 23:13, 2018 November 25

CCI component 2 codes - what was done
Procedure: Pharmacotherapy, thrombolytic agent
CCI 2 code: 35.HA-1C
CCI Collection Mode: CCI collect each

This procedure is a part of CCI Collection. This is one of the CCI component 2 codes - what was done.

Additional Info

  • Includes use of any thrombolytic agent
    • alteplase (Activase),
    • streptokinase (Streptase),
    • tissue plasminogen activator (TPA),
    • tenecteplase (TNK-tPA)
    • tetaplase (Retavase),
    • urokinase (Abbokinase),
  • Does not include clot stabilizer agents such as any sort of heparin, coumadin, aspirin or other NSAIDs, clopidogrel or any other anti-platelet agent.

Alternate CCIs to consider coding instead or in addition

Other procedure in Pharmacotherapy:
 Has CCI Picklist CodeHas CCI 1 CodeHas CCI 2 Code
CAR-T (Chimeric Antigen Receptor T-cell Immunotherapy)XW043C3

Related ICD10 Codes

Related Articles

Related articles:


CCI_Picklist CCI component 1 codes - what organ was something done to CCI component 2 codes - what was done